Protection against cardiac hypertrophy by geniposide involves the GLP-1 receptor / AMPKα signalling pathway
Author:
Affiliation:
1. Department of Cardiology; Renmin Hospital of Wuhan University; Wuhan China
2. Cardiovascular Research Institute of Wuhan University; Wuhan China
Funder
Fundamental Research Funds for the Central Universities of China
National Natural Science Foundation of China
Publisher
Wiley
Subject
Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13449/fullpdf
Reference57 articles.
1. The Concise Guide to PHARMACOLOGY 2015/16: G Protein-Coupled Receptors;Alexander;Br J Pharmacol,2015a
2. The Concise Guide to PHARMACOLOGY 2015/16: Enzymes;Alexander;Br J Pharmacol,2015b
3. AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes;Balteau;Am J Physiol Heart Circ Physiol,2014
4. Enhanced expression of beta 3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase;Belge;Circulation,2014
5. Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte;Chan;J Biol Chem,2004
Cited by 93 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identification strategy of Fructus Gardeniae and its adulterant based on UHPLC/Q-orbitrap-MS and UHPLC-QTRAP-MS/MS combined with PLS regression model;Talanta;2024-01
2. The action mechanism by which C1q/tumor necrosis factor-related protein-6 alleviates cerebral ischemia/reperfusion injury in diabetic mice;Neural Regeneration Research;2023-12-15
3. Semaphorin‑3A alleviates cardiac hypertrophy by regulating autophagy;Experimental and Therapeutic Medicine;2023-11-28
4. AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine;Journal of Inflammation Research;2023-11
5. mTORC1 and SGLT2 Inhibitors—A Therapeutic Perspective for Diabetic Cardiomyopathy;International Journal of Molecular Sciences;2023-10-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3